Manufacturer Product Alerts
Visit this page for an up-to-date listing of manufacturer withdrawal or recall of therapy products.
Active Alerts
Announced | Manufacturer | Medication/Product Recall or Replacement | Patient Guidance |
---|---|---|---|
August 28, 2023 – Voluntary Recall | Takeda | Baxject II Reconstitution Device – Voluntary replacement of device packed in certain lot numbers of Recombinate and Rixubis. View announcement. | Patients are instructed to direct questions to their physician or their local Hemophilia Treatment Center. |
Archived Alerts
Announced | Manufacturer | Medication/Product Recall or Replacement | Patient Guidance |
---|---|---|---|
January 20, 2021 | CSL Behring | Mononine - Voluntary Product Recall Notification | Patients are instructed to direct questions regarding the recall, risks, or possible adverse effects from this medication, to their physician or their local Hemophilia Treatment Center. |
July 19, 2019 – Voluntary Recall | BAYER | Kogenate® FS – View FDA Website | Patients are instructed to direct questions regarding the recall, risks, or possible adverse effects from this medication, to their physician or their local Hemophilia Treatment Center. Patients may also contact the FDA at 1.800.332.1088 or visit the FDA's website for further information. |
Patient Resources
Learn About Hemophilia (cdc.gov)
Learn About Von Willebrand Disease (VWD) (cdc.gov)
Hemophilia Treatment Centers